Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHAR for RA with Inadequate Response to Methotrexate
NCT01984268Phase 2Terminated
- Sponsor
- Dartmouth Health
- Start
- Jun 2014
- Primary completion
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of corticotropin in rheumatoid arthritis (RA), sponsored by Dartmouth Health. Started Jun 2014; status: terminated.
02
Drugs
corticotropin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01984268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01984268.